Mesocortical Dopamine Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The mesocortical dopamine pathway is a major dopaminergic neural circuit that projects from the ventral tegmental area (VTA) in the midbrain to the prefrontal cortex (PFC). This pathway is essential for higher-order cognitive functions including working memory, attention, decision-making, and cognitive control. The mesocortical system is distinct from the mesolimbic pathway (which targets limbic structures) and the nigrostriatal pathway (which targets the basal ganglia).
The mesocortical dopamine system plays a critical role in modulating prefrontal cortical function. Dopamine signaling in the PFC is dynamically regulated and follows an inverted-U shaped curve, where both too little and too much dopamine can impair cognitive function. This pathway is particularly vulnerable in several neurodegenerative and psychiatric disorders.
The mesocortical pathway is affected in AD, contributing to cognitive decline:
While not purely neurodegenerative, mesocortical dysfunction is central to schizophrenia:
The study of Mesocortical Dopamine Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Arnsten AF. Catecholamine influences on dorsolateral prefrontal cortical networks. Biol Psychiatry. 2011;69(12):e89-e99. PMID:21489411
Goldman-Rakic PS. The prefrontal cortex: anatomical and functional overview. Aphasiology. 1996;10(9):831-844.
Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987;44(7):660-669. PMID:3606332
Sesack SR, Grace AA. Cortico-basal ganglia reward network: microcircuitry. Neuropsychopharmacology. 2010;35(1):27-47. PMID:19675534
Williams SM, Goldman-Rakic PS. Widespread origin of the primate mesofrontal dopamine system. Cereb Cortex. 1998;8(4):321-345. PMID:9675923
Moore H, West AR, Grace AA. The regulation of forebrain dopamine transmission: the role of prefrontal cortical neurons. Ann N Y Acad Sci. 1999;877:175-198. PMID:10415652
Robbins TW, Arnsten AF. The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci. 2009;32:267-287. PMID:19555290
Sawaguchi T, Goldman-Rakic PS. D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science. 1991;251(4996):947-950. PMID:1825731
Category: Cell Types | Brain Region: Midbrain | Neurotransmitter: Dopamine